Connect with us

Technology

Waystar Announces Amendment to Its Credit Facilities

Published

on

Enhancements expected to boost flexibility and lower borrowing costs

LEHI, Utah and LOUISVILLE, Ky., Dec. 30, 2024 /PRNewswire/ — Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced an amendment to its first lien credit agreement (the “amended credit agreement”) with its lenders. The amendment reprices Waystar’s term loan and increases its revolving credit facility.

Under the amended agreement, the term loan will now carry a reduced interest rate of adjusted SOFR +2.25%, down from the previous interest rate of adjusted SOFR +2.75%. In addition, Waystar will increase its revolving credit facility borrowing capacity to $400 million, up from $342.5 million, and lower the interest rate to adjusted SOFR +1.75%, compared to the previous interest rate of adjusted SOFR +2.25%. These changes are expected to reduce borrowing costs and generate interest expense savings for the company.

The amendments follow Waystar’s successful initial public offering on June 7, 2024, with net proceeds used to reduce debt, as well as an earlier loan repricing on June 27, 2024.

Additional details about the amended credit agreement are available in Waystar’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 30, 2024. The filing is available on the investor relations page of Waystar’s website at investors.waystar.com.

Forward-Looking Statements
This press release contains forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that reflect our current views with respect to, among other things, future borrowing costs, interest expense savings, and the impact of the amended credit agreement. Forward-looking statements include all statements that are not historical facts. These statements may include words such as “believe,” “could,” “expect,” “may,” “potential,” “predict,” “project,” “future,” “will,” the negative version of these words or similar terms and phrases to identify forward-looking statements in this press release.

The forward-looking statements contained in this press release are based on management’s current expectations and are not guarantees of future performance. The forward-looking statements are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs, and projections are expressed in good faith, and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, and projections will result or be achieved. The following factors are among those that may cause actual results to differ materially from the forward-looking statements: our ability to successfully execute on our business strategies in order to grow; the heavily regulated industry in which we conduct business; the uncertain and evolving healthcare regulatory and political framework; reduced revenues in response to changes to the healthcare regulatory landscape; legal, regulatory, and other proceedings that could result in adverse outcomes; contractual obligations requiring compliance with certain provisions of the Bank Secrecy Act and anti-money laundering laws and regulations; any changes in our tax rates, the adoption of new tax legislation, or exposure to additional tax liabilities; restrictive covenants in the agreements governing our credit facilities; interest rate fluctuations; unavailability of additional capital on acceptable terms or at all; the impact of general macroeconomic conditions; actions of certain of our significant investors, who may have different interests than the interests of other holders of our securities; and each of the other factors discussed under the heading of “Risk Factors” in the Company’s prospectus filed with the Securities and Exchange Commission (the “SEC”) on June 7, 2024 and in other reports filed with the SEC, all of which are available on the Investor Relations page of our website at investors.waystar.com.

Any forward-looking statements made by us in this press release speak only as of the date of this press release and are expressly qualified in their entirety by the cautionary statements included in this press release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. You should not place undue reliance on our forward-looking statements. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by any applicable securities laws.

About Waystar
Waystar’s mission-critical software is purpose-built to simplify healthcare payments so providers can prioritize patient care and optimize their financial performance. Waystar serves approximately 30,000 clients, representing over 1 million distinct providers, including 16 of 20 institutions on the U.S. News Best Hospitals Honor Roll. Waystar’s enterprise-grade platform annually processes over 5 billion healthcare payment transactions, including over $1.2 trillion in annual gross claims and spanning approximately 50% of U.S. patients. Waystar strives to transform healthcare payments so providers can focus on what matters most: their patients and communities. Discover the way forward at waystar.com.

Investor Contact
Sandy Draper
investors@waystar.com

Media Contact
Kristin Lee
kristin.lee@waystar.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/waystar-announces-amendment-to-its-credit-facilities-302340397.html

SOURCE Waystar

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Accord Specialty Pharmacy Named Finalist in MMIT’s 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Published

on

By

ORLANDO, Fla., April 23, 2026 /PRNewswire/ — Accord Specialty Pharmacy, an independent specialty pharmacy serving patients across multiple states, has been named a finalist in the MMIT Patient Choice Awards, a recognition based on patient-reported satisfaction and experience.

Accord was selected as the only independent pharmacy among finalists in its category, alongside national pharmacy organizations such as Walgreens Specialty Pharmacy and Walmart Specialty Pharmacy. This distinction highlights the company’s commitment to delivering personalized, high-touch care for patients managing complex and chronic conditions.

The MMIT Patient Choice Awards recognize specialty pharmacies that demonstrate excellence in patient satisfaction, service quality, and overall care experience. Finalists are determined based on direct patient feedback, making the recognition a meaningful reflection of the trust patients place in their pharmacy providers.

“Being recognized alongside national organizations and as the only independent finalist validates our belief that personalized, patient-centered care drives better outcomes. We are building a model that combines clinical depth, national reach, and operational flexibility to better serve patients, providers, and partners.” said AJ Patel, Founder and Pharmacy Manager of Accord Specialty Pharmacy.

Accord Specialty Pharmacy supports patients across complex specialty categories, including oncology, rare disease, and infusion, through a clinically driven, high-touch care model designed to improve access, adherence, and outcomes. The company’s approach emphasizes personalized support, responsive care coordination, and strong clinical engagement to help patients navigate complex therapies more effectively. With a growing national footprint and multi-state licensure, Accord is positioned to support patients, providers, and partners across diverse markets.

For more information, visit MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards – MMITNetwork.

About Accord Specialty Pharmacy:

Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for individuals managing complex and chronic conditions. Through personalized support, clinical expertise, and a high-touch approach, Accord helps patients navigate every step of their treatment journey. Learn more at www.accordspecialty.com.

CONTACT: contact@accordspecialty.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accord-specialty-pharmacy-named-finalist-in-mmits-11th-annual-retail-specialty-pharmacy-patient-choice-awards-302752327.html

SOURCE Accord Specialty

Continue Reading

Technology

HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS

Published

on

By

MONTRÉAL, April 23, 2026 /CNW/ – Haivision Systems Inc. (“Haivision” or the “Company”) (TSX: HAI) is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format.

A total of approximately 45.97 % of the issued and outstanding common shares of Haivision were represented at the meeting.

Election of Directors

Each of the six nominated directors of Haivision was elected as director of the Company with the following results:

Director

Votes
For

% Votes
For

Votes
Against

% Votes
Against

Miroslav Wicha

11,110,245

99.26 %

82,583

0.74 %

Harvey Bienenstock

11,155,137

99.66 %

37,691

0.34 %

Robin M. Rush

11,121,855

99.37 %

70,973

0.63 %

Neil Hindle

10,794,005

96.44 %

398,823

3.56 %

Julie Tremblay

10,941,969

97.76 %

250,859

2.24 %

Lee K. Levy II

9,084,418

81.16 %

2,108,410

18.84 %

2.   Appointment of Auditors

Deloitte LLP were reappointed auditors of the Company for the ensuing year with 12,492,582 (98.84%) votes cast in favour and 146,406 (1.16%) votes withheld.

3.   Approval of the Unallocated Awards under the Company’s Equity Incentive Plan

The Company’s unallocated awards were approved with 8,710,347 (77.82%) votes cast in favour and 2,482,481 (22.18%) votes cast against.

4.   Reapproval of Company’s Shareholder Rights Plan

The Company’s shareholder rights plan was approved with 10,572,490 (94.46%) votes cast in favour and 620,338 (5.54%) votes cast against.

Final voting results on all matters voted on at the meeting will be filed under Haivision’s profile on SEDAR+ at www.sedarplus.ca.

About Haivision

Haivision is a leading global provider of mission-critical, real-time video streaming and visual collaboration solutions. Our connected cloud and intelligent edge technologies enable organizations globally to engage audiences, enhance collaboration, and support decision making. We provide high quality, low latency, secure, and reliable live video at a global scale. Haivision open sourced its award-winning SRT low latency video streaming protocol and founded the SRT Alliance to support its adoption. Awarded four Emmys® for Technology and Engineering from the National Academy of Television Arts and Sciences, Haivision continues to fuel the future of IP video transformation. Founded in 2004, Haivision is headquartered in Montreal and Chicago with offices, sales, and support located throughout the Americas, Europe, and Asia. Learn more at haivision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/haivision-announces-voting-results-from-2026-annual-meeting-of-shareholders-302752318.html

SOURCE Haivision Systems Inc.

Continue Reading

Technology

Noritz upgrades EZ Pro Series of tankless water heaters with larger, multi-function panel display for faster installation and servicing

Published

on

By

Improved, fully integrated diagnostic interface eliminates the need for a separate remote controller, providing key system status data and enhanced digital controls to ease startup, operation, and maintenance for pro installers and service techs.

FOUNTAIN VALLEY, Calif., April 23, 2026 /PRNewswire/ — Noritz America, an international leader in tankless and electric heat pump water heaters and high-efficiency combination boilers, has further enhanced its EZ Series Pro line of residential condensing tankless water heaters by expanding both the size and the functionality of the units’ built-in control panel, whose user-friendly digital interface is mounted prominently on the front exterior.

Providing upgraded monitoring and diagnostic capabilities, the multi-function panel display allows professional installers to view system status, temperature settings, service reminders, maintenance data, error codes, error history, and (if applicable) recirculation timing settings. All of this vital information is built in and readily accessible on the water heater. Besides eliminating the need for a separate, external remote controller, the panel enables guided setup during installation and faster, more effective troubleshooting.

In addition, installers and users can monitor and program the unit remotely via Bluetooth® connectivity that works alongside the panel, using the EZ Start Plus app on their smartphones. A separate external remote is optional.

“The intent of our upgrade efforts was to create a more satisfying user experience for both the professional and the consumer,” says Noritz Executive Vice President and General Manager Jason Fleming. “We focused on simplified installation, advanced diagnostics, and giving professionals and their customers easier, more responsive control of the water heater.”

Essential Features of the Multi-Function Panel

Below are the main features and capabilities of the upgraded, built-in, multi-function panel and related control system:

Digital temperature control: Professional installers and service technicians will find it easier to use the enlarged panel to set the output water temperature to 100° – 140° Fahrenheit. Temperature settings are available in increments as small as 5°F.

Key benefits: More precise temperature control for professionals and, as a result, safer, more consistent hot-water delivery for end users.

Integrated Bluetooth connectivity; no more dip switches: The EZ Start Plus app enables installers and service techs to perform system setup, adjust the temperature, run diagnostics and share this information electronically with Noritz Technical Support. Installers can even register the water heater to qualify for the accompanying warranty.

Key benefits: Simplified startups mean faster installs, minimizing the manual programming that installers previously had to perform. Smartphone-based control and troubleshooting eliminate the need for old-style manual adjustment of physical dip switches.

Improved service access: Even the physical design of the EZ Series Pro has been reengineered to work more effectively with the newly enhanced multi-function panel.

Key benefits: The latched, snap-lock front cover enables quicker access to components for easier maintenance and servicing.

Industry-Best Warranty

The upgraded EZ Series Pro continues to include three models, all with a Uniform Energy Factor of 0.98, the highest efficiency rating in the tankless water heater industry:

EZ71: input range — 12,800 to 160,000 BTU/hour; flow rate — 0.4 to 9.0 gallons per minute; turndown ratio — 12.5:1EZ98: 12,800 to 180,000 BTUh; 0.4 to 9.8 gpm; 14:1;EZ111: 12,800 to 199,900 BTUh; 0.4 to 11.1 gpm; 16:1.

All three units carry a 25-year limited warranty on their stainless steel heat exchangers, the longest such protection in the industry. Further protection includes a five-year limited parts warranty and one year for reasonable labor.

The water heaters use natural gas but are field-convertible to LP with a parts kit included with every unit. Two water heaters can be linked using Noritz’s optional Quick Connect linkage to double the hot-water flow rate.

Designed for wall-mounting indoors, the EZ Series Pro heaters can be direct-vented with two-, three-, or four-inch Schedule 40 or Schedule 80 PVC or CPVC, or two-inch or three-inch polypropylene venting. They can also be installed outdoors in milder year-round climates using an optional vent cap.

All EZ Series Pro models have received approvals from CSA, NSF5, NSF372, and are Low NOx approved by the South Coast Air Quality Management District (Rule 1146.2).

For more information on the newly upgraded Noritz EZ Series Pro, visit: https://ezseries.noritz.com/

A short product video is available at: https://youtu.be/m5iDn7sOGMc

For more information on the full line of Noritz tankless water heating products, visit www.noritz.com. You can also contact us by telephone at 866.766.7489 or by email at support@noritz.com.

For editorial assistance, contact John O’Reilly or Emma Wurzer at GreenHouse Digital PR, 15255 South 94th Avenue, Suite 500 | Orland Park, IL 60462; tel.: 708.428.6385; e-mail: john@greenhousedigitalpr.com | emma@greenhousedigitalpr.com.

Hi-res versions of photographs to accompany this press release are available for immediate download by using this link: https://noritz.greenhousedigitalpr.com/ez-series-pro-upgrades.

NORITZ AMERICA CORPORATION, a subsidiary of Noritz Japan, has corporate offices in Fountain Valley, Calif., and Atlanta, offering a full line of tankless water heaters and high-efficiency combination boilers to meet the hot water demands of residential and commercial applications. Noritz supports its products with a national network of skilled representatives and employees committed to providing our communities with the finest products and services by helping consumers live a more comfortable, efficient, and healthy lifestyle. For more information on Noritz America and the entire line of Noritz’s ENERGY STAR® tankless water heaters, please call (877) 986-6748 or visit our website at www.noritz.com.

CONTACT:
Andrew Tran
Noritz America
(714) 433-7813
atran@noritz.com

View original content:https://www.prnewswire.com/news-releases/noritz-upgrades-ez-pro-series-of-tankless-water-heaters-with-larger-multi-function-panel-display-for-faster-installation-and-servicing-302752319.html

SOURCE Noritz

Continue Reading

Trending